Pramodini Medicare IPO — Broker Reviews
Analyst Consensus
1
Subscribe
0
Neutral
0
Avoid
Dilip Davda
11 August 2026
subscribe_long_term
PML is engaged in providing diagnostic services in India, currently having presence in 7 states. The company marked growth in its top and bottom lines for the reported periods. Its outperforming margins compared to listed peers for the last three fiscals raise concern over sustainability going forward, as it operates in a highly competitive and fragmented segment. Based on its recent strong financial data, the issue appears aggressively priced. Only well-informed/cash surplus investors may park moderate funds for the long term.
Disclaimer: Broker reviews are for informational purposes only and do not constitute investment advice.